Ohno Masato, Zempo Nobuya, Jinzai Yuki, Sakashita Hideki, Uetsuki Tomohiko, Okada Takayuki
Division of Vascular Surgery, Kansai Medical University Hospital, Hirakata, Osaka, Japan.
Department of Cardiovascular Surgery, Kansai Medical University, Hirakata, Osaka, Japan.
Ann Vasc Dis. 2024 Sep 25;17(3):222-227. doi: 10.3400/avd.oa.24-00078. Epub 2024 Aug 21.
To evaluate the mid-term outcomes following thoracic endovascular aortic repair (TEVAR) for chronic type B aortic dissection (TBD), especially to know which re-entry closure affects the thoracic false lumen remodeling in the late chronic TBD. : From April 2017 to April 2022, 25 patients with chronic TBD underwent TEVAR. The late chronic TBD received the re-entry closure including stent-graft deployment in the renal artery, infrarenal aorta, and unilateral or bilateral iliac artery. : Complete shrinkage of the thoracic false lumen was accomplished in 67% of the early chronic cases but only 13% of the late chronic cases. The thoracic false lumen shrinkage over 5 mm in diameter was obtained in 78% of the early chronic cases and 69% of the late chronic cases. Univariate and multiple logistic regression analyses revealed the re-entry closure of common or external iliac artery affects the thoracic false lumen remodeling. : The re-entry closure in the common or external iliac artery could affect the thoracic false lumen remodeling following TEVAR for the late chronic TBD. (This is a translation of Jpn J Vasc Surg 2023; 32: 351-356).
评估胸主动脉腔内修复术(TEVAR)治疗慢性B型主动脉夹层(TBD)的中期疗效,尤其是了解哪种再入路闭合方式会影响晚期慢性TBD患者的胸段假腔重塑。:2017年4月至2022年4月,25例慢性TBD患者接受了TEVAR治疗。晚期慢性TBD患者接受了再入路闭合,包括在肾动脉、肾下腹主动脉以及单侧或双侧髂动脉置入覆膜支架。:早期慢性病例中67%的患者胸段假腔完全缩小,而晚期慢性病例中仅有13%。早期慢性病例中78%、晚期慢性病例中69%的患者胸段假腔直径缩小超过5mm。单因素和多因素logistic回归分析显示,髂总动脉或髂外动脉的再入路闭合影响胸段假腔重塑。:对于晚期慢性TBD患者,TEVAR术后髂总动脉或髂外动脉的再入路闭合可能影响胸段假腔重塑。(本文翻译自《日本血管外科学杂志》2023年;32:351 - 356)